References

Unresolved reference

2011 · External reference

Tumour stem cells and drug resistance

10.1038/nrc1590 · 2005 · External reference

Colon cancer stem cells: implications in carcinogenesis

10.2741/3811 · 2011 · External reference

Phenotypic characterization of human colorectal cancer stem cells

10.1073/pnas.0703478104 · 2007 · External reference

Age-related increase in colorectal cancer stem cells in macroscopically normal mucosa of patients with adenomas: a risk factor for colon cancer

10.1016/j.bbrc.2008.10.179 · 2009 · External reference

Cancer stem cells

10.1056/nejmra061808 · 2006 · External reference

Difluorinated-curcumin (CDF): a novel curcumin analog is a potent inhibitor of colon cancer stem-like cells

10.1007/s11095-010-0336-y · 2011 · External reference

Elimination of colon cancer stem-like cells by the combination of curcumin and FOLFOX

10.1593/tlo.09193 · 2009 · External reference

MicroRNA-21 induces stemness by downregulating transforming growth factor beta receptor 2 (TGFβR2) in colon cancer cells

10.1093/carcin/bgr246 · 2012 · External reference

A microRNA in a multiple-turnover RNAi enzyme complex

10.1126/science.1073827 · 2002 · External reference

MicroRNA: implications for cancer

10.1007/s00428-007-0532-2 · 2008 · External reference

Advantages of genomic complexity: bioinformatics opportunities in microRNA cancer signatures

10.1136/amiajnl-2011-000419 · 2012 · External reference

MicroRNA-21 promotes cell transformation by targeting the programmed cell death 4 gene

10.1038/onc.2008.72 · 2008 · External reference

MicroRNA-21: from cancer to cardiovascular disease

10.2174/138945010791591403 · 2010 · External reference

The diverse functions of microRNAs in animal development and disease

10.1016/j.devcel.2006.09.009 · 2006 · External reference

Combination of dasatinib and curcumin eliminates chemo-resistant colon cancer cells

10.1186/1750-2187-6-7 · 2011 · External reference

Curcumin enhances the effects of 5-fluorouracil and oxaliplatin in mediating growth inhibition of colon cancer cells by modulating EGFR and IGF-1R

10.1002/ijc.23097 · 2008 · External reference

Curcumin targets FOLFOX-surviving colon cancer cells via inhibition of EGFRs and IGF-1R

2010 · External reference

Epidermal growth factor receptor (EGFR)-related protein inhibits multiple members of the EGFR family in colon and breast cancer cells

10.1158/1535-7163.mct-04-0280 · 2005 · External reference

The Wnt/β-catenin pathway regulates growth and maintenance of colonospheres

10.1186/1476-4598-9-212 · 2010 · External reference

OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma

10.1038/nature09284 · 2010 · External reference

MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer

10.1038/sj.onc.1210856 · 2008 · External reference

Gastrointestinal differentiation marker Cytokeratin 20 is regulated by homeobox gene CDX1

10.1073/pnas.0812904106 · 2009 · External reference

Activation of β-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC

10.1126/science.275.5307.1787 · 1997 · External reference

Wnt/beta-catenin/tcf signaling: a critical pathway in gastrointestinal tumorigenesis

10.1159/000066755 · 2002 · External reference

Mutational analysis of the APC/β-catenin/Tcf pathway in colorectal cancer

1998 · External reference

Induction of glutathione peroxidase 4 expression during enterocytic cell differentiation

10.1074/jbc.m110.216028 · 2011 · External reference

Schlafen-3 decreases cancer stem cell marker expression and autocrine/juxtacrine signaling in FOLFOX-resistant colon cancer cells

10.1152/ajpgi.00403.2010 · 2011 · External reference

Gemcitabine sensitivity can be induced in pancreatic cancer cells through modulation of miR-200 and miR-21 expression by curcumin or its analogue CDF

10.1158/0008-5472.can-09-4598 · 2010 · External reference